Drreddys Laboratories reported 10.91B in EBIT for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Ani Pharmaceuticals ANIP:US $ -19195000 1.8M
Aurora Cannabis Inc ACB:CN C$ -110537000 13M
Bayer BAYN:GR 4.17B 704M
Canopy Growth Corp WEED:CN -304230000 192.32M
Catalent CTLT:US $ 216M 38M
Cipla CIPLA:IN 4.59B 5.24B
Corcept Therapeutics CORT:US $ 26.77M 9.9M
Endo International Ordinary Shares ENDP:US $ 120.25M 52.02M
GlaxoSmithKline GSK:LN 2.42B 724M
Hikma Pharmaceutical HIK:LN 279M 1000K
Horizon Pharma HZNP:US 196.44M 99.18M
JAZZ PHA JAZZ:US 87.55M 105.43M
Lannett LCI:US $ -20301000 2.47M
Lonza Group LONN:SW 551M 48M
Novartis NOVN:VX 3.15B 266M
Pacira Pharmaceuticals PCRX:US $ 21.73M 24.09M
Phibro Animal Health PAHC:US $ 19.19M 3.1M
Prestige Brands PBH:US $ 77.42M 5.17M
Richter Gedeon RICHT:HB 37.46B 8.83B
Sun Pharmaceuticals SUNP:IN 16.23B 4.4B
Supernus Pharmaceuticals SUPN:US $ 1.97M 26.43M
Teva Pharmaceutical TEVA:IT 789M 182M